Akari Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor.

CEO

Abizer Gaslightwala

CEOAbizer Gaslightwala

Employees

Employees9

Headquarters

Tampa, Florida

HeadquartersTampa, Florida

Founded

2004

Founded2004

Employees

Employees9

AKTX Key Statistics

Market cap

23.01M

Market cap23.01M

Price-Earnings ratio

-0.11

Price-Earnings ratio-0.11

Dividend yield

—

Dividend yield—

Average volume

113.77K

Average volume113.77K

High today

$0.7437

High today$0.7437

Low today

$0.70

Low today$0.70

Open price

$0.731

Open price$0.731

Volume

90.58K

Volume90.58K

52 Week high

$3.15

52 Week high$3.15

52 Week low

$0.5714

52 Week low$0.5714

Akari Therapeutics

Why Robinhood?

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. Show more

AKTX Key Statistics

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor.